These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28657604)

  • 21. A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss.
    Crujeiras AB; Parra MD; Rodríguez MC; Martínez de Morentin BE; Martínez JA
    Nutrition; 2006 Jun; 22(6):593-9. PubMed ID: 16704952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
    Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study.
    Recaredo G; Marin-Alejandre BA; Cantero I; Monreal JI; Herrero JI; Benito-Boillos A; Elorz M; Tur JA; Martínez JA; Zulet MA; Abete I
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
    Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
    Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.
    de Piano A; Tock L; Carnier J; Oyama LM; Oller do Nascimento CM; Martinz AC; Foschini D; Sanches PL; Ernandes RM; de Mello MT; Tufik S; Dâmaso AR
    Metabolism; 2010 May; 59(5):613-9. PubMed ID: 19942238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
    Perez-Diaz-Del-Campo N; Marin-Alejandre BA; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Abete I; Zulet MA
    Eur J Nutr; 2021 Sep; 60(6):3043-3057. PubMed ID: 33474638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in lysophospholipids and liver status after weight loss: the RESMENA study.
    Cantero I; Abete I; Del Bas JM; Caimari A; Arola L; Zulet MA; Martinez JA
    Nutr Metab (Lond); 2018; 15():51. PubMed ID: 30026784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control.
    Zulet MA; Bondia-Pons I; Abete I; de la Iglesia R; López-Legarrea P; Forga L; Navas-Carretero S; Martínez JA
    Nutr Hosp; 2011; 26(1):16-26. PubMed ID: 21519726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity as a protective factor for development of non-alcoholic fatty liver in men.
    Pinto CG; Marega M; Carvalho JA; Carmona FG; Lopes CE; Ceschini FL; Bocalini DS; Figueira Junior AJ
    Einstein (Sao Paulo); 2015; 13(1):34-40. PubMed ID: 25993066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustainable weight loss among overweight and obese lactating women is achieved with an energy-reduced diet in line with dietary recommendations: results from the LEVA randomized controlled trial.
    Bertz F; Winkvist A; Brekke HK
    J Acad Nutr Diet; 2015 Jan; 115(1):78-86. PubMed ID: 25088520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
    Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
    Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study.
    Takahashi F; Hashimoto Y; Kawano R; Kaji A; Sakai R; Kawate Y; Okamura T; Ushigome E; Kitagawa N; Majima S; Sennmaru T; Okada H; Nakanishi N; Hamaguchi M; Asano M; Yamazaki M; Fukui M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32707957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.
    Marin-Alejandre BA; Abete I; Monreal JI; Elorz M; Benito-Boillos A; Herrero JI; Navarro-Blasco I; Tur JA; Bandarra NM; Zulet MA; Martinez JA
    J Clin Lipidol; 2020; 14(6):837-849.e2. PubMed ID: 32962964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.